A government-owned vaccine technology that could be used to develop universal flu vaccines is now available for licensing, the National Institutes of Health announced. NIH is making the invention available for licensing to expedite commercialization of an influenza vaccine that does not require yearly reformulation and that could be used to protect against seasonal and pandemic-potential influenza viruses. “Influenza virus is a major public health concern, causing up to 500,000 deaths annually,” the agency says in a Friday (April 9)...